Compliance · Data protection

Can pharmacies message patients on WhatsApp and SMS?

In short

Yes, with two conditions. Messages about a patient's own care, such as prescription-ready texts and appointment reminders, need no marketing consent under PECR or NHS England guidance. Anything promotional needs PECR consent, and since 5 February 2026 breaches can be fined at UK GDPR levels. Clinical information belongs only on a platform your pharmacy has approved and records.

Most pharmacies already text patients, and many staff have a WhatsApp thread with a regular customer somewhere on their phone. The rules are clearer than they look. PECR decides when a message needs consent, UK GDPR and the GPhC decide how patient information travels, and NHS England has already written down what a safe messaging policy contains. This guide puts the three together.

Last reviewed 2 April 2026 by Arham Jamaal, Superintendent Pharmacist. Marketing rules are from PECR regulations 22 and 23 as amended by the Data (Use and Access) Act 2025 and the ICO's direct marketing guidance; care-messaging rules are from NHS England's IG guidance on texting patients and the GPhC's confidentiality and distance-selling guidance.

Can you text a patient that a prescription is ready without consent?

Yes. A prescription-ready text, a collection reminder or an appointment confirmation is a message about the patient's own care. NHS England's guidance on texting, emailing and messaging patients puts it plainly: "You do not need the consent of patients and service users to send them texts, emails or other messages about their individual care". The guidance identifies public task under Article 6(1)(e) and the provision of health care under Article 9(2)(h) of UK GDPR as the lawful bases for NHS-funded care. A private pharmacy relies on its contract with the patient or on legitimate interests for Article 6, and on Article 9(2)(h) for the health data.

The common law duty of confidentiality is satisfied the same way. NHS England says it is appropriate to rely on implied consent to communicate with people about their care, because patients reasonably expect it. The GPhC's guidance on confidentiality, updated in November 2025, says explicit consent is needed only where the reason for sharing is one the person "would not reasonably expect".

Three practical conditions still apply. Confirm the mobile number and let the patient state a contact preference; NHS England calls this good practice at registration and asks you to respect it where practical. Keep the content minimal: the guidance says to include confidential information only where necessary, unless the platform is one your organisation has approved for sensitive data. "Your prescription is ready to collect" gives nothing away. "Your sertraline is ready" does. And write the message from a system that records it, which we come to below.

When does a message become marketing?

The moment it promotes something. The ICO defines direct marketing as "the communication (by whatever means) of advertising or marketing material which is directed to particular individuals". Its guidance says messages that confirm or remind people about appointments, or update them on terms and conditions, are service messages and not direct marketing. The test is purpose: "the focus is on why you are doing something rather than the activity itself".

Mixed messages fail that test. The ICO's own example is a gym calling about a failed payment and mentioning personal training on the same call. Because the gym is also promoting its services, the call "now falls within the definition of direct marketing". The pharmacy equivalent is a prescription-ready text that ends "ask about our new weight management clinic". The whole message is now marketing, and it needed PECR consent before it was sent.

NHS England treats invitations to NHS-commissioned care, such as a flu vaccination for an eligible patient, as care messaging. Its guidance notes that the duty of confidentiality still applies when staff search records to decide who to message. Promotion of a private service to people who have not asked about it is marketing, whatever the clinical merit. If you are unsure, ask whether the message would still be sent if the patient never bought anything again. A reminder would. An offer would not.

PECR consent, to the UK GDPR standard. Regulation 22(2) of the Privacy and Electronic Communications (EC Directive) Regulations 2003 is the rule. A person shall not send unsolicited direct marketing "by means of electronic mail" unless the recipient has previously told the sender that they consent. Regulation 2 defines electronic mail as "any text, voice, sound or image message" sent over a public network and stored until collected. It adds that the term "includes messages sent using a short message service". The ICO's list covers email, SMS, picture and video messages, voicemail, in-app messages and private messages on social media. A marketing WhatsApp is caught in the same way as a marketing text.

The ICO describes the consent standard as a "freely given, specific, informed and unambiguous indication" of the person's wishes. People "must take a positive action to consent", so pre-ticked boxes, silence or inactivity do not count. The one exception is the soft opt-in in regulation 22(3). The table summarises the rules as the ICO's guidance on direct marketing using electronic mail sets them out.

RuleWhat it requiresSource
ConsentPositive, specific, informed opt-in before any marketing by SMS, email, picture message, in-app or private social message.PECR reg 22(2); ICO guidance.
Soft opt-inDetails collected directly during a sale or negotiation, marketing only for similar products or services, a free and simple opt-out at collection and in every message.PECR reg 22(3).
Identity and opt-outNever disguise or hide who is sending; give a valid address for opt-outs, for example "text STOP to 12345".PECR reg 23; ICO guidance.
Health data in marketingA special category condition as well as a lawful basis; explicit consent as a clear statement, kept separate from other consents.ICO direct marketing guidance.
WithdrawalStop as soon as someone opts out and keep a suppression list.ICO guidance.
PenaltiesRegulation 22 and 23 breaches attract the higher maximum: £17.5 million or 4 per cent of worldwide turnover.PECR Schedule 1, in force 5 February 2026; DPA 2018 s.157.

The penalty line is new. The Data (Use and Access) Act 2025 substituted PECR's enforcement provisions from 5 February 2026, applying the Data Protection Act 2018 penalty regime to marketing breaches. The ICO's PECR guide still quotes the old £500,000 ceiling while its guidance is under review, so do not take the old figure from a search result. The soft opt-in is also narrower than it looks for a pharmacy. It covers "similar products or services", and the ICO requires a special category condition where marketing draws on health information. A list of patients who bought a particular medicine is health data. Marketing to it needs explicit consent, not an inference from a purchase. Our guide to marketing emails under PECR covers the consent mechanics in detail.

Is WhatsApp secure enough for patient information?

Not as most pharmacies use it. The question is not whether the messages are encrypted in transit. It is who controls the device, the backups, the account and the record. NHS England's guidance for professionals is direct: "You should not use any app, service, platform or device which has not been approved by your organisation, except for in emergencies". Its guidance for IG leads requires a data protection impact assessment before a new platform is adopted. It also requires staff policies, multi-factor authentication, encryption of data at rest and a rule that staff do not share devices or passwords.

A consumer WhatsApp account on a personal phone fails on every count. The pharmacy has no contract with the platform as its processor, no control over cloud backups, no way to retrieve the thread when the staff member leaves and no audit trail. The ICO's reprimand to NHS Lanarkshire on 31 July 2023, for "the sharing of personal data of patients via unauthorised means", is the reference case for staff messaging outside approved systems. The GPhC frames the same duty for individuals. Standard 7 requires pharmacy professionals to respect and maintain confidentiality and privacy. Its confidentiality guidance asks them to "take all reasonable steps to protect the confidentiality and security of information they receive, access, store, send or destroy". Its January 2024 guidance on professionalism online lists "share information about patients or their care" under the things not to do.

That leaves two lawful routes. The first is a business messaging service, whether SMS, a patient app or a WhatsApp business integration, contracted as your processor, assessed in a DPIA and connected to the record. The second is the NHS App, which NHS England names as a secure platform through which confidential information may be sent. What does not work is the responsible pharmacist's own handset. Our guide to protecting patient data covers the controls a DPIA will expect to see.

Should messages be saved in the patient record?

Yes, all of them. NHS England's guidance says: "You should keep a record of all the emails, texts or other messages you send to patients and service users in their health or care record". Its IG guidance adds that relevant messages must be retrievable, for example by entering them into the record. The GPhC's February 2025 guidance for pharmacies providing services at a distance requires records of the advice given and the key points behind every decision to supply or refuse. A message that changed a decision is part of that record.

Software does this for you; phones do not. A reminder sent from the PMR is logged against the patient with a timestamp and a sender. A WhatsApp sent from a handset exists only on that handset until someone copies it in. Inbound messages matter as much as outbound ones. A patient replying "I've stopped taking it" or "I've had a reaction" has told you something you must act on and record. Our guide to recording patient notes on a PMR explains how to structure that entry, and our companion piece on record retention periods sets out how long it must be kept.

Can patients send photos for a consultation?

Only through an approved platform that writes to the record. A photo of a rash, a wound, a medication box or a set of bathroom scales is confidential patient information, and often special category data. On a personal phone it sits in the camera roll, syncs to a personal cloud account and outlives the consultation with no audit trail. Every rule in the previous two sections applies to it.

The clinical governance point is separate. The GPhC's distance-selling guidance requires a means of "timely two-way communication between the prescriber and the person", and records showing the basis for each supply. For weight-management medicines it goes further. The prescriber must independently verify the person's weight, height or BMI, and the guidance states that a phone call is not an appropriate way to do it. A photo the patient took of their own scales is not independent verification either. Our guide to the verification duties for weight-loss supply sets out what inspectors accept. Photos can support a consultation. They cannot replace the parts of it the regulator has told you to do properly.

Which channel should you use for what?

Match the channel to the sensitivity of the content and the need for a record. The table below is a working rule set drawn from the ICO, NHS England and GPhC documents above. It is not a list of approved products.

MessageChannelConsent and record
Prescription ready, collection slot or appointment reminderSMS or email from the PMR or an approved serviceNo marketing consent; confirmed number and preference; logged automatically.
Results ready, please call usSMS or NHS App messageNo consent; keep the result out of the text; logged.
Clinical advice, side-effect query, dose changeApproved two-way platform, telephone or video, then written into the recordImplied consent for care; full note in the record.
Photos or documents for a consultationSecure upload within the consultation platformStored in the record; never on a personal device.
New private service, offer or newsletterAny electronic channelPECR consent or valid soft opt-in; identity shown; STOP or unsubscribe in every message.
Anything on a staff member's personal WhatsAppNot used, except in an emergencyCopy any emergency exchange into the record the same day.
WHAT THIS MEANS FOR YOU

Separate the two consents in your systems. "Contact me about my prescriptions by text" is a care preference and needs no tick box. "Send me offers and news" is PECR marketing consent and needs a positive, separate, recorded opt-in with an opt-out in every message. If your PMR or website holds them as one field, you are either failing to send legitimate reminders or sending unlawful marketing. Our guide to reminders and recalls in Dataforge PMR shows how the two are kept apart in practice.

What should your messaging policy say?

Write it before the next inspection or the next complaint, whichever comes first. NHS England expects an organisation to have approved platforms, a DPIA for each, staff procedures and device controls. The GPhC expects the superintendent to be able to show that confidentiality is protected and that records exist. The checklist below turns those expectations into a one-page policy.

A messaging policy in eight lines
  • Name the approved channels for care messages and for marketing, and state that personal messaging apps are not used except in an emergency.
  • Record each patient's mobile number and contact preference at registration, and re-check the number before any clinical message.
  • Keep care messages minimal: no medicine names, results or diagnoses unless the platform is approved for sensitive data.
  • Hold PECR marketing consent as a separate, dated, positive opt-in, with STOP or unsubscribe in every message and a suppression list.
  • Log every message, inbound and outbound, in the patient record, and set a same-day rule for anything sent in an emergency from a phone.
  • Complete a DPIA for each messaging platform, with a processor contract, multi-factor authentication and encryption at rest.
  • Ban shared logins and shared devices, and remove access on the day a staff member leaves.
  • Train the team on the marketing line, using the ICO's mixed-message example, and review the policy yearly.

Key takeaways

  • Care messages such as prescription-ready texts need no consent: NHS England's guidance says so, and the ICO does not treat service messages as direct marketing.
  • Any promotional content makes the whole message direct marketing, which needs PECR consent under regulation 22 or a valid soft opt-in.
  • Since 5 February 2026 PECR marketing breaches carry the UK GDPR higher maximum of £17.5 million or 4 per cent of turnover.
  • Marketing built on what patients bought is health data and needs explicit, separate consent.
  • NHS England's guidance bars unapproved apps and devices except in emergencies, so consumer WhatsApp on a personal phone is out.
  • Every message, in both directions, belongs in the patient record; a PMR does this automatically and a handset does not.
  • Photos can support a consultation on an approved platform, but they are not independent verification for weight-loss supply.

Sources and further reading

FAQs

Yes. A text telling a patient their prescription is ready is a service message about their own care, not direct marketing, so the PECR consent rule does not apply. NHS England's guidance on texting patients says you do not need consent to message people about their individual care. You do need the right number, a record of the patient's contact preference, and a message that gives away no more than necessary. Add a promotion and the same text becomes marketing.
AJ
WRITTEN BY
Arham Jamaal
Superintendent Pharmacist · Published researcher, pharmacokinetics
This article summarises the rules on messaging patients that apply to pharmacies in England as at 2 April 2026: PECR, UK GDPR and the Data Protection Act 2018, ICO direct marketing guidance, NHS England information governance guidance and GPhC guidance. The ICO has said its PECR guidance is under review following the Data (Use and Access) Act 2025. Platform terms of service change frequently and are not summarised here. Check the current documents before relying on a rule. General guidance for professionals rather than legal, medical or regulatory advice. Last reviewed 2 April 2026.

Reminders that go out from the record, not from a phone.

Dataforge PMR sends reminders and recalls from inside the patient record, so each message is logged against the patient. Whatever system you use, check that it holds marketing consent separately from care contact preferences.

See Dataforge PMR

Keep reading